Observed Signal · Mar 17, 2026 · Product Launch · Source: https://martechseries.com/feed/ · Impact: 3/5 · Sentiment: Positive
Persistent and NVIDIA Revolutionize Drug Discovery with AI
Persistent Systems announced a collaboration with NVIDIA to accelerate AI-powered solutions for the Healthcare and Life Sciences (HLS) sector, advancing computational drug discovery through generative models and agentic workflows. Persistent has built a Generative Molecules and Virtual Screening solution (GenMoIVS / GenMolVS) that leverages NVIDIA BioNeMo, the NeMo Agent Toolkit and NVIDIA AI Enterprise to run high-fidelity molecular simulation and virtual screening at scale. The solution intends to enable continuous decisioning across virtual screening, candidate prioritization and experimental planning, translating digital simulations into informed wet-lab experiments. Persistent plans to use NVIDIA Nemotron open models and NVIDIA NIM microservices and will deploy on NVIDIA-accelerated compute and servers. The partnership also includes leveraging NVIDIA training resources and certifications to expand Persistent’s AI and LLM engineering capabilities for production-grade deployments in regulated research environments.
A production-grade solution built on NVIDIA’s full-stack AI platform demonstrates expanded enterprise adoption of agentic AI and GPU-accelerated infrastructure; this matters to industry players relying on NVIDIA tooling for scalable AI deployments, though the announcement is specific to healthcare/life sciences rather than core AdTech/MarTech.
Track NVIDIA Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Persistent Systems announced a collaboration with NVIDIA to accelerate AI solutions for the Healthcare and Life Sciences industry.
- Persistent created a Generative Molecules and Virtual Screening solution (GenMoIVS / GenMolVS) powered by NVIDIA BioNeMo and the NVIDIA NeMo Agent Toolkit.
- The solution will use NVIDIA AI Enterprise, NVIDIA Nemotron open models, NVIDIA NIM microservices, and NVIDIA-accelerated compute/servers for production deployments.
- GenMoIVS/GenMolVS delivers AI-driven molecular simulations and agentic workflows for virtual screening, candidate prioritization, and downstream experimental planning.
- Persistent will leverage NVIDIA infrastructure, training resources and certification programs to expand its AI and LLM engineering capabilities for clients.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Adobe and NVIDIA Unite for AI-Powered Creative Revolution
Adobe and NVIDIA announced a strategic partnership to accelerate AI-powered creation, production and personalization across creative and marketing workflows. The collaboration will jointly develop the next generation of Adobe Firefly models and advance agentic workflows using NVIDIA’s accelerated computing, CUDA-X, NeMo libraries, NVIDIA Cosmos open models, and the NVIDIA Agent Toolkit (including NemoClaw/OpenShell). Adobe will integrate NVIDIA technologies across its products (Photoshop, Premiere Pro, Acrobat, Frame.io, Adobe Experience Platform, Firefly Foundry and GenStudio) and launch a cloud-native, brand-preserving 3D digital twin solution (public beta) built with NVIDIA Omniverse and OpenUSD. NVIDIA will provide engineering expertise, early software access and go-to-market support to deliver enterprise-grade, IP-protected generative AI capabilities for marketing, media and production pipelines.
Drug Discovery and AI Agents Scale with New Compute
Roche is deploying a new AI factory containing 2,176 Nvidia Blackwell GPUs, pushing its installed GPU count past 3,500 as it treats compute as core infrastructure for end-to-end drug discovery. This follows Eli Lilly’s $1B AI lab push and Roche’s report of 25% faster molecule design, framing discovery as high-throughput, iterative compute (described here as 'tokenized' inference workloads). Separately, Google Research introduced TurboQuant, a compression algorithm that can shrink the KV cache inside large models by up to 6x and speed inference, which could materially extend agent memory and long-context reasoning. The newsletter also notes Apple is reportedly rebuilding Siri into a system-level, chat/agent experience, and raises questions about Unitree’s IPO metrics. Together these items signal growing demand for large-scale GPU infrastructure, advances in model-efficiency that enable longer agent workflows, and platform-level shifts in conversational agents.
LangChain and NVIDIA Launch Advanced AI Development Platform
LangChain announced a comprehensive integration with NVIDIA to deliver an enterprise-grade agentic AI development platform that combines LangChain’s LangSmith, LangGraph and Deep Agents frameworks with NVIDIA’s Agent Toolkit and infrastructure (Nemotron models, NeMo Agent Toolkit, NIM microservices, Dynamo and OpenShell). LangChain is joining NVIDIA’s Nemotron Coalition. The joint stack targets building, deploying and monitoring production-grade AI agents at scale with optimizations for parallel and speculative execution, throughput improvements via NIM microservices, unified observability through LangSmith and NeMo tooling, and model benchmarking across the Nemotron family (Nano, Super, Ultra). The collaboration positions developers to reduce custom infra work and accelerate production agent deployments with built-in profiling, guardrails, and evaluation tooling.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.